Conclusion
This study revealed that fetal EFT was significantly increased in
diabetic pregnancies with either PGDM or GDM but the increase in fetal
EFT was significantly higher in PGDM compared to GDM. Furthermore, fetal
EFT is strongly correlated with maternal blood glucose levels in
diabetic pregnancies. Therefore, fetal EFT value could be used as a
prognostic marker for PGDM and GDM and also for adverse perinatal
outcomes related to diabetes.
Research funding: None
declared.
Author contributions: All authors have accepted responsibility
for the entire content of this manuscript and approved its submission.
Disclosure of interest: The authors report no conflict of
interest.
Informed consent: Informed consent was obtained from all
individuals included in this study.
Ethical approval: The
research related to human use complied with all the relevant national
regulations, instutional policies, and in accordance with the tenets of
the Helsinki Declaration, and has been approved by the authors’
Institutional Review Board or equivalent committee (Izmir Tepecik
Training and Research Hospital Ethics Committee, decision no:
2021/02-50)